Alajab M, Ibn Auf B, Rafei A, Abdo A
Ann Med Surg (Lond). 2024; 86(9):5091-5095.
PMID: 39239022
PMC: 11374274.
DOI: 10.1097/MS9.0000000000002337.
Lee G, Purdy M, Choi Y
Life (Basel). 2023; 13(7).
PMID: 37511902
PMC: 10381383.
DOI: 10.3390/life13071527.
Caviglia G, Ciancio A, Rizzetto M
Viruses. 2022; 14(8).
PMID: 36016371
PMC: 9414459.
DOI: 10.3390/v14081749.
Saracco G, Marzano A, Rizzetto M
Biomedicines. 2022; 10(3).
PMID: 35327336
PMC: 8945793.
DOI: 10.3390/biomedicines10030534.
Oberhardt V, Hofmann M, Thimme R, Neumann-Haefelin C
Viruses. 2022; 14(2).
PMID: 35215790
PMC: 8880046.
DOI: 10.3390/v14020198.
Hepatitis D virus (HDV): investigational therapeutic agents in clinical trials.
Asif B, Koh C
Expert Opin Investig Drugs. 2021; 31(9):905-920.
PMID: 34482769
PMC: 11391510.
DOI: 10.1080/13543784.2021.1977795.
From hepatitis A to E: A critical review of viral hepatitis.
Castaneda D, Gonzalez A, Alomari M, Tandon K, Zervos X
World J Gastroenterol. 2021; 27(16):1691-1715.
PMID: 33967551
PMC: 8072198.
DOI: 10.3748/wjg.v27.i16.1691.
Hepatitis D Virus: A Call to Screening.
Ahn J, Gish R
Gastroenterol Hepatol (N Y). 2016; 10(10):647-86.
PMID: 27540336
PMC: 4988222.
Hepatitis delta virus: Making the point from virus isolation up to 2014.
Romeo R, Perbellini R
World J Hepatol. 2015; 7(22):2389-95.
PMID: 26464754
PMC: 4598609.
DOI: 10.4254/wjh.v7.i22.2389.
Therapy of Delta Hepatitis.
Yurdaydin C, Idilman R
Cold Spring Harb Perspect Med. 2015; 5(10).
PMID: 26253093
PMC: 4588130.
DOI: 10.1101/cshperspect.a021543.
Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide.
He W, Ren B, Mao F, Jing Z, Li Y, Liu Y
PLoS Pathog. 2015; 11(4):e1004840.
PMID: 25902143
PMC: 4406467.
DOI: 10.1371/journal.ppat.1004840.
Animal models of chronic hepatitis delta virus infection host-virus immunologic interactions.
Aldabe R, Suarez-Amaran L, Usai C, Gonzalez-Aseguinolaza G
Pathogens. 2015; 4(1):46-65.
PMID: 25686091
PMC: 4384072.
DOI: 10.3390/pathogens4010046.
Prevalence of hepatitis D virus in hepatitis B virus infected patients referred to Taleghani hospital, Tehran, Iran.
Tahaei S, Mohebbi S, Azimzadeh P, Behelgardi A, Sanati A, Mohammadi P
Gastroenterol Hepatol Bed Bench. 2014; 7(3):144-50.
PMID: 25120894
PMC: 4129564.
Life cycle and pathogenesis of hepatitis D virus: A review.
Abbas Z, Afzal R
World J Hepatol. 2014; 5(12):666-75.
PMID: 24409335
PMC: 3879688.
DOI: 10.4254/wjh.v5.i12.666.
Control of ADAR1 editing of hepatitis delta virus RNAs.
Casey J
Curr Top Microbiol Immunol. 2011; 353:123-43.
PMID: 21732238
PMC: 3572862.
DOI: 10.1007/82_2011_146.
Hepatitis: PEG-IFN for the treatment of hepatitis D.
Ciancio A, Rizzetto M
Nat Rev Gastroenterol Hepatol. 2011; 8(6):304-6.
PMID: 21643035
DOI: 10.1038/nrgastro.2011.85.
Delta hepatitis: molecular biology and clinical and epidemiological features.
Polish L, Gallagher M, Fields H, Hadler S
Clin Microbiol Rev. 1993; 6(3):211-29.
PMID: 8358704
PMC: 358283.
DOI: 10.1128/CMR.6.3.211.
Hepatitis viruses: changing patterns of human disease.
Purcell R
Proc Natl Acad Sci U S A. 1994; 91(7):2401-6.
PMID: 8146130
PMC: 43379.
DOI: 10.1073/pnas.91.7.2401.
Apparent helper-independent infection of woodchucks by hepatitis delta virus and subsequent rescue with woodchuck hepatitis virus.
Netter H, Gerin J, Tennant B, Taylor J
J Virol. 1994; 68(9):5344-50.
PMID: 8057418
PMC: 236934.
DOI: 10.1128/JVI.68.9.5344-5350.1994.
An RNA tertiary structure of the hepatitis delta agent contains UV-sensitive bases U-712 and U-865 and can form in a bimolecular complex.
Branch A, Levine B, Polaskova J
Nucleic Acids Res. 1995; 23(3):491-9.
PMID: 7885846
PMC: 306702.
DOI: 10.1093/nar/23.3.491.